Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

BACKGROUND: Bisphosphonates are recommended for use as first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis in adults. However, the appropriate usage of bisphosphonates for the prevention or treatment of glucocorticoid-induced osteoporosis in children remains un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Rheumatol Online J
Main Authors: Inoue, Yuzaburo, Mitsunaga, Kanako, Yamamoto, Takeshi, Chiba, Koki, Yamaide, Fumiya, Nakano, Taiji, Morita, Yoshinori, Yamaide, Akiko, Suzuki, Shuichi, Arima, Takayasu, Yamaguchi, Ken-ichi, Tomiita, Minako, Shimojo, Naoki, Kohno, Yoichi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006935/
https://ncbi.nlm.nih.gov/pubmed/29914510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-018-0258-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados